Fagron vs Marek Health

Vial Take

Both cover the same core menu, including TRT, HRT, peptides, and metabolic health, and Fagron actually sits inside Marek's supply chain as a named pharmacy partner, so if you've used Marek you've likely already been dispensed Fagron product. The meaningful gap is transparency: Marek publishes its pharmacy partners and confirms physician oversight across 45 states, while Fagron discloses neither, which is normal for a wholesale compounder but means you're getting less visibility into the clinical layer. Where Fagron earns its trust score is on federal compliance, a clean record across FDA, OIG, DEA, and HIPAA; where Marek earns its higher score is on the full-platform picture, lab depth, clinical structure, and supply-chain openness that a pharmacy-only operation simply isn't built to offer.

Biggest Differences

1. 1
   Pharmacy disclosure
   Marek Health publishes its compounding partners (Empower Pharmacy, Fagron), so you can verify the supply chain; Fagron does not name a pharmacy partner publicly.
2. 2
   Operating history
   Fagron has been operating since 1990 (36+ years of visible track record); Marek Health launched in 2019, giving you 29 fewer years of public record to evaluate.